Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 1174

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 9
Chunk 1174
---
 1,177,568 common shares pursuant to the HCW ATM agreement with H.C. Wainwright & Co., LLC for net proceeds of approximately $3.4 million, after deducting sales agent commissions. In addition, subsequent to September 30, 2025, the Company granted an aggregate of 21,642 restricted share units under its equity incentive plan. During the same period, 14,472 RSUs were settled in an equivalent number of common shares. Subsequent to September 30, 2025, the Company entered into certain service agreements with third-party service providers related to its research and development activities. Under the terms of these agreements, the Company may be required to make future payments of up to an aggregate of approximately $4.2 million, contingent upon the scope of services performed and terms of the underlying agreements.

F-25